Begin main content

Dapagliflozin

Last Updated: April 1, 2015
Result type: Reports
Project Number: SR0428-000
Product Line: Common Drug Review

Generic Name: Dapagliflozin

Brand Name: Forxiga

Manufacturer: AstraZeneca Canada Inc.

Indications: Diabetes mellitus (Type 2)

Submission Type: New

Project Status: Active

Date Recommendation Issued: November 20, 2015

Recommendation Type: List with clinical criteria and/or conditions

Tags

diabetes mellitus, type 2, drug combinations, drug therapy, combination, polypharmacy, diabetes